Clinical Trials Directory

Trials / Unknown

UnknownNCT05507034

Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.

sCANsens: Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Universiteit Antwerpen · Academic / Other
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Up to 40% of women experience chronic pain after treatment for breast cancer, and this pain is often very disabling. However, chronic pain after breast cancer remains under-recognised and undertreated. An effective and patient-tailored approach of (chronic) pain after breast cancer indeed requires a thorough knowledge and evaluation of the pain. In daily clinical practice, however, guidelines for a comprehensive diagnosis of pain in cancer patients and survivors are lacking. Further research in this topic is crucial for an efficient, preventive as well as curative, approach of pain after breast cancer. Besides the high prevalence and the important impact of pain in this population, the breast cancer population is also an ideal population to study chronic pain and its natural time course in different stages, since most patients start pain-free, but almost half of them end up with chronic pain. Therefore, this study aims to map biomarkers (both predictive, prognostic and diagnostic) for chronic pain after breast cancer treatment. We will study possible biopsychosocial biomarkers in relation to (chronic) pain and monitor their temporal changes from the moment of diagnosis until 1 year after surgery. The potential biomarkers are situated within the medical imaging of the brain, measurements of pain sensitivity and psychological variables.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiomarkersEach intervention is performed at 4 timepoints namely: before surgery, i.e. baseline (T0), 1-3 weeks post-surgery (T1), 3 months post-surgery (T2) and 1 year post-surgery (T4)

Timeline

Start date
2022-10-04
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2022-08-18
Last updated
2023-12-27

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05507034. Inclusion in this directory is not an endorsement.